Impact of the Modulator Elexacaftor Tezacaftor Ivacaftor (ETI) on the Complexity of Prescriptions and the Clinical Stage of Children and Adolescents With Cystic Fibrosis. RSD 2026, 15 (1), e7715150550. https://doi.org/10.33448/rsd-v15i1.50550.